300060110023

Vioxx, known generically as rofecoxib, was a medication developed by Merck Sharp & Dohme used primarily to treat pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and acute pain. It was classified as a nonsteroidal anti-inflammatory drug (NSAID) and was intended to provide pain relief while minimizing gastrointestinal side effects often associated with traditional NSAIDs.

The barcode 300060110023 corresponds to a specific package of Vioxx that contains 2 tablets of 25 mg each and is classified as a Doctor Sample. This means the package was intended for distribution by healthcare providers to patients for evaluation or trial purposes, rather than for general sale.

It is critical to note that Vioxx was withdrawn from the market in 2004 due to significant safety concerns. Research indicated an increased risk of cardiovascular events, including heart attacks and strokes, associated with the long-term use of the drug. Consequently, healthcare providers are typically cautious about prescribing it, and patients are advised to discuss the risks and benefits of any treatment thoroughly.

As for pricing, while it can vary based on location and pharmacy availability, Vioxx was previously reported to be priced around $60-$80 USD for a 2-tablet package of 25 mg. However, as the drug has been withdrawn, it may not be available in all areas or at these prices anymore.

Regarding health-related disclaimers, Vioxx carries significant warnings due to its association with serious cardiovascular risks. Such warnings are critical and may be specified in patient information leaflets provided by healthcare providers or listed in the medication's prescribing information.

If you need additional information or have specific health-related questions, consulting a healthcare professional is recommended, as they can provide guidance tailored to individual health needs and conditions.